Last week, the vitamin market remained generally stable. VC manufacturers raised prices, leading to increased market attention and actual transaction prices rising. Deliveries of products such as B2, K3, and B12 remained tight, with market prices staying firm.
Last week, the amino acid market showed divergent trends, with overall trading sentiment subdued and few large transactions. Except for methionine, most products faced downward pressure and lacked positive support. Valine experienced oversupply, with domestic prices at 11.5-12.5 RMB/KG and a significant drop in export prices this week to 1.6-1.7 USD/KG. Tryptophan saw sluggish inquiry activity, with manufacturers slightly lowering quotes to 31.5-33 RMB/KG, while end-users made only essential replenishment purchases, leading to a weak market. For arginine and isoleucine, transaction prices fell to 23-23.5 RMB/KG and 27-30 RMB/KG, respectively. Methionine, however, saw tightening spot supply due to manufacturers halting price announcements, restricting sales, and production line maintenance, with market prices holding steady at 38.0-40.5 RMB/KG. Short-term prices are expected to remain stable or show a slight upward trend.
Last week, in the sweetener series of the food additives sector, sucralose saw stable transaction prices influenced by raw material market conditions, with market transactions at 97-99 RMB/KG, and the possibility of subsequent price increases cannot be ruled out. Sodium saccharin anhydrous maintained stable prices due to market transactions, currently with market transaction prices around 51-53 RMB/KG. In terms of nutritional fortifiers, creatine monohydrate prices stabilized under market conditions, with market transaction prices steady at around 25-26 RMB/KG, and delivery schedules arranged up to June.
On May 29, IFF announced that it has reached an agreement with global private equity investment firm CVC Capital Partners to sell its Food Ingredients business to a fund managed by CVC. According to the terms of the transaction, the business is valued at approximately $4.3 billion, corresponding to an enterprise value-to-EBITDA multiple of about 10 times. At the same time, IFF will retain a minority stake of approximately 10%, valued at around $200 million, in order to continue collaborating with the Food Ingredients business and share in the benefits of future value growth.
Leave a Reply
Your email is safe with us.